![]() |
![]() |
Legal status
Patent not validated
(51) | INT.CL. | A61K 38/17 | (2006.01) |
A61K 38/177 | (2013.01) | ||
A61K 48/00 | (2006.01) | ||
C07K2319/30 | (2013.01) | ||
A61P 25/28 | (2006.01) | ||
C07K 14/70596 | (2013.01) | ||
C07K 14/705 | (2006.01) | ||
A61K 47/68 | (2017.08) | ||
A61K 47/68 | (2017.01) | ||
A61P 25/28 | (2018.01) | ||
A61P 25/16 | (2006.01) | ||
A61P 25/16 | (2018.01) |
(11) | Number of the document | 3624838 |
(13) | Kind of document | T |
(96) | European patent application number | 18801838.6 |
Date of filing the European patent application | 2018-05-15 | |
(97) | Date of publication of the European application | 2020-03-25 |
(45) | Date of publication and mention of the grant of the patent | 2023-01-25 |
(46) | Date of publication of the claims translation |
(86) | Number | PCT/US2018/032699 |
Date | 2018-05-15 |
(87) | Number | WO 2018/213266 |
Date | 2018-11-22 |
(30) | Number | Date | Country code |
201762506135 P | 2017-05-15 | US |
(72) |
LIU, Yang , US
ZHENG, Pan , US
LI, Ning , US
DEVENPORT, Martin , US
|
(73) |
Oncoimmune, Inc. ,
9430 Key West Avenue
Suite 113, Rockville, Maryland 20850,
US
Children's National Medical Center , 111 Michigan Avenue N.W., Washington, DC 20010, US |
(54) | METHODS OF USE OF SOLUBLE CD24 FOR NEUROPROTECTION AND REMYELINATION |
METHODS OF USE OF SOLUBLE CD24 FOR NEUROPROTECTION AND REMYELINATION |